These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31536750)

  • 21. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep Disturbance and Alzheimer's Disease: The Glial Connection.
    Sunkaria A; Bhardwaj S
    Neurochem Res; 2022 Jul; 47(7):1799-1815. PubMed ID: 35303225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology.
    Stefanova NA; Maksimova KY; Kiseleva E; Rudnitskaya EA; Muraleva NA; Kolosova NG
    J Pineal Res; 2015 Sep; 59(2):163-77. PubMed ID: 25988948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis.
    Lucey BP; Bateman RJ
    Neurobiol Aging; 2014 Sep; 35 Suppl 2():S29-34. PubMed ID: 24910393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.
    Colby-Milley J; Cavanagh C; Jego S; Breitner JC; Quirion R; Adamantidis A
    PLoS One; 2015; 10(6):e0130177. PubMed ID: 26076358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's disease.
    Van Egroo M; Narbutas J; Chylinski D; Villar González P; Maquet P; Salmon E; Bastin C; Collette F; Vandewalle G
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30649520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Synergistic Relationship between Alzheimer's Disease and Sleep Disorders: An Update.
    Villa C; Ferini-Strambi L; Combi R
    J Alzheimers Dis; 2015; 46(3):571-80. PubMed ID: 25835421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model.
    Adler P; Mayne J; Walker K; Ning Z; Figeys D
    J Proteome Res; 2019 Sep; 18(9):3383-3393. PubMed ID: 31334659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Karageorgiou E; Vossel KA
    Alzheimers Dement; 2017 Sep; 13(9):1054-1067. PubMed ID: 28302453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease?
    Yulug B; Hanoglu L; Kilic E
    Psychiatry Clin Neurosci; 2017 Oct; 71(10):673-677. PubMed ID: 28523718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locus Coeruleus Dysfunction and Trigeminal Mesencephalic Nucleus Degeneration: A Cue for Periodontal Infection Mediated Damage in Alzheimer's Disease?
    Pisani F; Pisani V; Arcangeli F; Harding A; Singhrao SK
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep disturbances in Alzheimer's and Parkinson's diseases.
    Rothman SM; Mattson MP
    Neuromolecular Med; 2012 Sep; 14(3):194-204. PubMed ID: 22552887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer's Disease.
    Minakawa EN; Wada K; Nagai Y
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
    Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
    J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.